TNNI3 and heart failure: Finally, the clinical relevance of hs-cTnI and hs-cTnT assay for an early and accurate detection of asymptomatic individuals at higher risk of progressing to symptomatic heart failure (HF) or developing major adverse cardiovascular events (MACE) will be suggested [15,16].